Heart Failure and Cardiomyopathies
There is no content available at this time. Please check again later.
Relevant Content
2026 AHA/ACC Clinical Performance and Quality Measures for Patients With Atrial Fibrillation
Methodologic Standards for Follow-Up Extension in Cardiovascular Trials
Stroke ... Communities ... ASCVD Risk Calculator HCM-AF Risk Calculator Combined Adult/Pediatric Hypertrophic Cardiomyopathy Calculator for Risk of Sudden ... HCM SCD Risk Calculator
HeartBEATS from Lifelong Learning™, Science Series: Opioid-Associated Out-of-Hospital Cardiac Arrest
Extension follow-up studies address long-term questions beyond the parent...
Exercise Training in High-Risk Populations
Despite proven health benefits, regular exercise and fitness training rema...
Variant Site-Specific Natural History of Titin-Induced Cardiomyopathy: An International Multicenter Registry
Circulation: Genomic and Precision Medicine, Ahead of Print.
BACKGROU...
Deprescribing in Patients With Cardiovascular Disease Experiencing Polypharmacy
BACKGROU...
Polypharmacy is common in cardiovascular (CV) care because guideline-direc...
Graded Associations Between Left Ventricular Ejection Fraction Improvement and Cardiorenal Outcomes in Heart Failure With Improved Ejection Fraction
Journal of the American Heart Association, Ahead of Print.
Background...
Clinical Course and Predictors of Heart Failure in Asymptomatic Obstructive Hypertrophic Cardiomyopathy
Background...
Journal of the American Heart Association, Ahead of Print.
Background...
Stanniocalcin‐1 Attenuates Cardiac Fibrosis Post Ischemia–Reperfusion Injury by Targeting the DOCKER Domain of Dedicator of Cytokinesis 1
Background...
Journal of the American Heart Association, Ahead of Print.
Background...
Prognostic Value of the Meta‐Analysis Global Group in Chronic Heart Failure Risk Score in Patients Undergoing Mitral Valve Transcatheter Edge‐to‐Edge Repair
Background...
Journal of the American Heart Association, Ahead of Print.
Background...
Background...